Europe Precision Medicine Market Size & Outlook, 2026-2033
Global Market
Related Markets
Europe precision medicine market highlights
- The Europe precision medicine market generated a revenue of USD 27,713.6 million in 2025.
- The market is expected to grow at a CAGR of 17.9% from 2026 to 2033.
- In terms of segment, therapeutics was the largest revenue generating application in 2025.
- Diagnostics is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 27,713.6 million |
| Market revenue in 2033 | USD 102,600.3 million |
| Growth rate | 17.9% (CAGR from 2026 to 2033) |
| Largest segment | Therapeutics |
| Fastest growing segment | Diagnostics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | Roche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares |
Other key industry trends
- In terms of revenue, Europe region accounted for 23.8% of the global precision medicine market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 103,571.6 million by 2033.
The burden of cancer continues to grow globally, exerting substantial pressure on patients, their families, communities, and healthcare systems. In Europe, cancer is the second-leading cause of death and morbidity, with over 3.7 million new cases and 1.9 million deaths each year. However, advancements in therapeutic approaches are bringing us closer to a future where cancer can be cured.
Over the past two decades, understanding of cancer has greatly improved, revealing significant variability not only between different cancer types but also among patients with the same type of cancer. This highlights the need for—and the promise of—tailoring cancer care to individual patient characteristics.
Fueled by this knowledge, cancer treatment is increasingly shifting toward PM, a healthcare approach that systematically uses patient data to inform personalized treatment decisions. The vision for precision medicine in cancer is transformative: to deliver superior outcomes for all cancer patients and ultimately reduce the suffering caused by cancer.
No credit card required*
Publish Date: May 12, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Precision Medicine Diagnostics Therapeutics Market
Precision Medicine Diagnostics Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| International Business Machines Corp | View profile | 282,200 | One New Orchard Road, Armonk, NY, United States, 10504 | www.ibm.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Myriad Genetics Inc | View profile | 2,700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | www.myriad.com |
| Dakota Software | View profile | 51-100 | Cleveland, Ohio, United States, North America | dakotasoft.com |
Europe precision medicine diagnostics therapeutics market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Precision Medicine Market Outlook will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 93.86% in 2025.
Horizon Databook has segmented the Europe precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2021 to 2033.
The burden of cancer continues to grow globally, exerting substantial pressure on patients, their families, communities, and healthcare systems. In Europe, cancer is the second-leading cause of death and morbidity, with over 3.7 million new cases and 1.9 million deaths each year. However, advancements in therapeutic approaches are bringing us closer to a future where cancer can be cured.
Over the past two decades, understanding of cancer has greatly improved, revealing significant variability not only between different cancer types but also among patients with the same type of cancer. This highlights the need for—and the promise of—tailoring cancer care to individual patient characteristics.
Fueled by this knowledge, cancer treatment is increasingly shifting toward PM, a healthcare approach that systematically uses patient data to inform personalized treatment decisions. The vision for precision medicine in cancer is transformative: to deliver superior outcomes for all cancer patients and ultimately reduce the suffering caused by cancer.
- Europe Precision Medicine Market Application Outlook (Revenue, USD Million , 2021-2033)
- Diagnostics
- Therapeutics
- Europe Precision Medicine Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Home Care
- Hospitals
- Clinical Laboratories
- Others
Reasons to subscribe to precision medicine diagnostics therapeutics market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of precision medicine diagnostics therapeutics market databook
- Our clientele includes a mix of precision medicine diagnostics therapeutics market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe precision medicine diagnostics therapeutics market, including forecasts for subscribers. This continent databook contains high-level insights into Europe precision medicine diagnostics therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Precision Medicine Market, 2021-2033 (US$M)
Europe Application - Precision Medicine Market Statistics, 2025 - 2033 (US$M)
